{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T23:01:38Z","timestamp":1754262098978},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2019,5,21]]},"DOI":"10.18632\/oncotarget.26931","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T13:26:35Z","timestamp":1558445195000},"page":"3373-3384","source":"Crossref","is-referenced-by-count":3,"title":["Melanoma patients with additional primary cancers: a single-center retrospective analysis"],"prefix":"10.18632","volume":"10","author":[{"given":"Florentia","family":"Dimitriou","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Mangana","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Curioni-Fontecedro","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Division of Oncology, University Hospital of Zurich, Zurich, Switzerland"},{"name":"Faculty of Medicine, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Rechsteiner","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Turko","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph P.","family":"Braun","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland"},{"name":"Faculty of Medicine, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland"},{"name":"Faculty of Medicine, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil F.","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/35094086","article-title":"Cancer genetics: from Boveri and Mendel to microarrays","volume":"1","author":"Balmain","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031","volume":"136","author":"Olsen","year":"2016","journal-title":"J Invest Dermatol"},{"key":"4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1242\/dev.106567","article-title":"The melanocyte lineage in development and disease","volume":"142","author":"Patton","year":"2015","journal-title":"Development"},{"key":"5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Long","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Kinzler","year":"2013","journal-title":"Science"},{"key":"7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Cancer Genome Atlas N, and Cancer Genome Atlas Network","year":"2015","journal-title":"Cell"},{"key":"8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1758834015616934","article-title":"Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy","volume":"8","author":"Ribas","year":"2016","journal-title":"Ther Adv Med Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune Checkpoint Blockade in Cancer Therapy","volume":"33","author":"Wolchok","year":"2015","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejca.2017.06.028","article-title":"Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017","volume":"83","author":"Garbe","year":"2017","journal-title":"Eur J Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Tucker","year":"2010","journal-title":"Arch Dermatol"},{"key":"12","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.1038\/s41598-018-25408-6","article-title":"An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry","volume":"8","author":"Smith","year":"2018","journal-title":"Sci Rep"},{"key":"13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clml.2017.06.028","article-title":"Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study","volume":"17","author":"Armitage","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/10428194.2016.1217527","article-title":"Secondary malignancies in patients with multiple myeloma, Waldenstr\u00f6m macroglobulinemia and monoclonal gammopathy of undetermined significance","volume":"58","author":"Gertz","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00432-018-2621-9","article-title":"Multiple primary non-breast tumors in breast cancer survivors","volume":"144","author":"Galimberti","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1200\/JCO.2013.51.1915","article-title":"Personal history of prostate cancer and increased risk of incident melanoma in the United States","volume":"31","author":"Han","year":"2013","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/hed.24937","article-title":"Second primary cancer after major salivary gland carcinoma","volume":"40","author":"M\u00e4kitie","year":"2018","journal-title":"Head Neck"},{"key":"18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/j.1365-2133.2012.11123.x","article-title":"Risk of second primaryand invasive melanoma in a Dutch population-based cohort: 1989-2008","volume":"167","author":"de Vries","year":"2012","journal-title":"Br J Dermatol"},{"key":"19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaad.2010.09.772","article-title":"Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry","volume":"66","author":"Garbe","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jaad.2015.02.006","article-title":"Risk of subsequent melanoma after melanomaand invasive melanoma: a population-based study from 1973 to 2011","volume":"72","author":"Weinstock","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Hemminki","year":"2000","journal-title":"N Engl J Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1073\/pnas.1221068110","article-title":"Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation","volume":"110","author":"Parmigiani","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"23","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1039\/C8PP00182K","article-title":"Solar UV damage to cellular DNA: from mechanisms to biological effects","volume":"17","author":"Mullenders","year":"2018","journal-title":"Photochem Photobiol Sci"},{"key":"24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semcancer.2012.02.003","article-title":"Melanoma-induced immunosuppression and its neutralization","volume":"22","author":"Sevko","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"e1408750","DOI":"10.1080\/2162402X.2017.1408750","article-title":"Melanoma induced immunosuppression is mediated by hematopoietic dysregulation","volume":"7","author":"Castro","year":"2017","journal-title":"OncoImmunology"},{"key":"26","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/sj.bjc.6603763","article-title":"Mechanisms of local immunosuppression in cutaneous melanoma","volume":"96","author":"Cree","year":"2007","journal-title":"Br J Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ijc.20322","article-title":"Association between female breast cancer and cutaneous melanoma","volume":"111","author":"Tsao","year":"2004","journal-title":"Int J Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","author":"Breast Cancer Linkage Consortium","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"29","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","article-title":"High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families","volume":"92","author":"Ingvar","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"30","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.jid.2018.01.021","article-title":"Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades","volume":"138","author":"Goldstein","year":"2018","journal-title":"J Invest Dermatol"},{"key":"31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1464-410X.2011.10736.x","article-title":"Prostate cancer incidence in Australia correlates inversely with solar radiation","volume":"108","author":"Khadra","year":"2011","journal-title":"BJU Int"},{"key":"32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10552-006-0050-6","article-title":"UV, latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States)","volume":"17","author":"Hanchette","year":"2006","journal-title":"Cancer Causes Control"},{"key":"33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(01)05788-9","article-title":"Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer","volume":"358","author":"Strange","year":"2001","journal-title":"Lancet"},{"key":"34","doi-asserted-by":"publisher","first-page":"E726","DOI":"10.1002\/ijc.27400","article-title":"Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: a case-control study","volume":"131","author":"Armstrong","year":"2012","journal-title":"Int J Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jaad.2016.01.061","article-title":"Pregnancy and melanoma","volume":"75","author":"Stein","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/jdv.14520","article-title":"Oestrogen receptor expression in melanoma","volume":"31","author":"Dummer","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"37","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0140-6736(80)91055-7","article-title":"Malignant melanoma: an androgen-dependent tumour?","volume":"1","author":"Mulder","year":"1980","journal-title":"Lancet"},{"key":"38","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/1538-7445.AM2013-1320","article-title":"Abstract 1320: effects of selective androgen-receptor and estrogen-receptor modulators on telomerase activity in melanoma and prostate cancer cells","volume":"73","author":"Miller","year":"2013","journal-title":"Cancer Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamaoto.2014.78","article-title":"Increased melanoma risk in individuals with papillary thyroid carcinoma","volume":"140","author":"Hunt","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Vastrik","year":"2007","journal-title":"Nature"},{"key":"41","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Ewing","year":"2002","journal-title":"Nature"},{"key":"42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"w14279","DOI":"10.4414\/smw.2016.14279","article-title":"The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma","volume":"146","author":"Arnold","year":"2016","journal-title":"Swiss Med Wkly"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T11:42:26Z","timestamp":1588851746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":43,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,5,21]]}},"alternative-id":["26931","31164959"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26931","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]}}}